Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Less invasive drainage may match surgery for abscess treatment

NCT ID NCT03819309

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tested whether a less invasive ultrasound-guided drainage procedure works as well as laparoscopic surgery for treating tubo-ovarian abscess. 208 women with uncomplicated abscess were randomly assigned to one of the two procedures, both combined with antibiotics. The main goal was to see if the drainage could achieve a similar cure rate at 6 weeks, defined by no need for further surgery or antibiotics and no large collection on ultrasound.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ultrasound-guided transvaginal drainage or laparoscopy
What this could lead to
If successful, this could show that a less invasive drainage procedure works as well as surgery for treating tubo-ovarian abscess, potentially reducing recovery time and complications.
What could go wrong
This is a completed trial, but results are not yet widely known. The non-inferiority design means it may not prove drainage is truly as good as laparoscopy, and individual outcomes vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

208 people

The number who actually took part.

Started

Apr 2019

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

"Inclusion criteria : * Major patient aged ≤ 50 at the time of inclusion * Patient hospitalized for TOA diagnosis defined by: * a high genital infection (major criteria of recommendations for the clinical practice of CNGOF): spontaneous pelvic pain and induced adnexal pain and / or uterine mobilization pain; * Visible ultrasound collection in the form of a latero-uterine mass measuring at least 3 cm detailed in the recommendations of the CNGOF: * tubal wall thickening\> 5 mm * OR sign of the gear wheel (thickened tubal fringes giving an incomplete septa appearance) * OR Heterogeneous lateral mass + / - compartmentalized with fine echoes * Biological inflammatory syndrome (defined by CRP\> 20 or white blood cell\> 10,000 / mm3) * Uncomplicated: good hemodynamic tolerance, not broken Exclusion criteria : * Suspected malignant tumor or Borderline * Complicated abscess: abscess rupture, generalized peritonitis, septic shock * Known HIV infection with CD4 count \<200 / mm3, immunosuppression * Patient already operated for TOA in progress * TOA not accessible to vaginal puncture * Multiple antecedents of abdominal surgeries that make it more difficult to surgically access the abdominopelvic cavity * Pregnancy in progress or breastfeeding * Patient with a contraindication to general anesthesia * Poor understanding of the French language * Patient under guardianship or curatorship * Patient under AVK without relay by LMWH possible * Known allergies or contraindications to any of the drugs used in the research * Patient participating in another interventional research protocol * No affiliation to the social security scheme or the CMU (universal health cover) * Absence of informed consent, written and signed"

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Uncomplicated tubo ovarian abscess are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Bichat-Claude Bernard

    Paris, 75018, France